Vaxcyte, Inc. (PCVX)

USD 30.78

(9.77%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 75 Million 9.19 Million 1.8 Million 1.4 Million 1.23 Million 1.03 Million
Gross Profit -75 Million -9.19 Million -1.8 Million -1.4 Million -1.23 Million -1.03 Million
Operating Expenses 468.04 Million 207.33 Million 102.08 Million 87.1 Million 53.91 Million 35.53 Million
Selling, General and Administrative Expenses 60.7 Million 39.81 Million 25.25 Million 16.01 Million 8.54 Million 5.38 Million
Research and Development Expenses 332.34 Million 169.45 Million 78.41 Million 73.56 Million 45.6 Million 30.14 Million
Other Expenses - -1.93 Million -1.58 Million -2.47 Million -237 Thousand 5.17 Million
Cost and Expenses 468.04 Million 207.33 Million 102.08 Million 87.1 Million 53.91 Million 35.53 Million
Operating Income -468.04 Million -232.25 Million -103.67 Million -89.58 Million -54.15 Million -35.53 Million
Interest Expense - 2000.00 7000.00 7000.00 40 Thousand 75 Thousand
Income Tax Expense - 16.15 Million 7000.00 -1.39 Million 3.22 Million 6.12 Million
Earnings before Tax -402.26 Million -223.48 Million -100.07 Million -89.21 Million -50.27 Million -29.48 Million
Net Income -402.26 Million -239.64 Million -100.08 Million -87.81 Million -53.49 Million -29.48 Million
Earnings Per Share Basic -4.14 -3.69 -1.93 -1.72 -1.09 -1.15
Earnings Per Share Diluted -4.14 -3.69 -1.93 -1.72 -1.09 -1.15
Weighted Average Shares Outstanding 97.15 Million 64.87 Million 51.92 Million 51.07 Million 48.85 Million 25.59 Million
Weighted Average Shares Outstanding (Diluted) 97.15 Million 64.87 Million 51.92 Million 51.07 Million 48.85 Million 25.59 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -464.88 Million -214.28 Million -98.27 Million -87.8 Million -49 Million -28.37 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts